How Linezolid’s Structure Shapes Its Antibacterial Activity
Approved by the FDA in 2000, Linezolid introduced the oxazolidinone class into clinical practice. Its activity against susceptible Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), made it useful where established antibiotics faced resistance. Its molecular architecture helps explain how it engages the bacterial ribosome. Three Parts of One Molecule The Linezolid […]
How Linezolid’s Structure Shapes Its Antibacterial Activity Read More »









